Steve Perrin, PhD

Steve Perrin, PhD, is Chief Scientific Officer of ALS Therapy Development Institute. Dr. Perrin is responsible for all aspects of the Research and Development organization. The goal of the Institute is to identify and develop new therapeutic candidates for Amyotrophic Lateral Sclerosis. Prior, Dr. Perrin was an Associate Director of Biomarker Discovery at Biogen Idec. He has also held positions of Principle Scientist of Genomics Technologies at Hoescht-Ariad Genomics Center and an Assistant Professor at Boston University Medical Center. Dr. Perrin has in depth knowledge of genomics, proteomics, computational biology, and drug discovery process. (This is me - Update Profile)